Characterization of a novel mutation in the F8 promoter region associated with mild hemophilia A and resistance to DDAVP therapy

J Thromb Haemost. 2009 Jul;7(7):1234-5. doi: 10.1111/j.1538-7836.2009.03468.x. Epub 2009 Apr 30.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Deamino Arginine Vasopressin / therapeutic use*
  • Factor VIII / genetics*
  • Female
  • Hemophilia A / drug therapy*
  • Hemophilia A / genetics
  • Humans
  • Male
  • Mutation*
  • Pedigree
  • Promoter Regions, Genetic*

Substances

  • Factor VIII
  • Deamino Arginine Vasopressin